Explore

Program Map

Start with a treatment, device, company, diagnosis, or trial ID. Each record keeps the source trail close to the claim.

161Main(26 active)

148Status checked

135Strong

320Backlog

More filters and sort (2 active)

Company-led only

1 records in Main database · 1 strong · 1 status checked

Compare	Program	Company	Type	Product	Modality	Stage	Status	Reliability	Evidence	Conf.	Population	Indications	Inspect
Add	SPI-1005 by Sound Pharmaceuticals	Sound Pharmaceuticals	Therapeutic	-	Small Molecule	Phase 3	Active	Details checkedStrong evidence	trial · Priority 1	90%	AdultNoise-Induced+2	Hearing LossSensorineural Hearing Loss+3

Sound Pharmaceuticals · Small Molecule · Phase 3

ActiveTherapeuticStronger sources

Evidence

trial

Confidence

90%

Indications

Hearing LossSensorineural Hearing LossNoise-Induced Hearing LossTinnitus

Population

AdultNoise-InducedTinnitusCisplatin Ototoxicity